{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:14:32Z","timestamp":1782918872777,"version":"3.54.5"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This research was funded by the Construction Fund of Medical Key Disciplines of Hangzhou","award":["OO20190001"],"award-info":[{"award-number":["OO20190001"]}]},{"name":"This research was funded by the Construction Fund of Medical Key Disciplines of Hangzhou","award":["OO20190001"],"award-info":[{"award-number":["OO20190001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03695-0","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T15:03:31Z","timestamp":1740236611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sialic acid metabolism-based classification reveals novel metabolic subtypes with distinct characteristics of tumor microenvironment and clinical outcomes in gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Junjie","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-2305","authenticated-orcid":false,"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"issue":"3","key":"3695_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3695_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina M, Arrazubi V, Diez M, Tabernero J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2023;20(3):155\u201370.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7517","key":"3695_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"5","key":"3695_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449\u201356.","journal-title":"Nat Med"},{"issue":"3","key":"3695_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/ijms21030722","volume":"21","author":"M Balmana","year":"2020","unstructured":"Balmana M, Diniz F, Feijao T, Barrias CC, Mereiter S, Reis CA. Analysis of the effect of increased \u03b12,3-sialylation on RTK activation in MKN45 gastric cancer spheroids treated with crizotinib. Int J Mol Sci. 2020;21(3):722.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3695_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104630","volume":"25","author":"D Yang","year":"2022","unstructured":"Yang D, Yin J, Shan L, Yi X, Zhang W, Ding Y. Identification of lysine-lactylated substrates in gastric cancer cells. iScience. 2022;25(7): 104630.","journal-title":"iScience"},{"key":"3695_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2019.03.043","volume":"453","author":"C Zhao","year":"2019","unstructured":"Zhao C, Tao T, Yang L, Qin Q, Wang Y, Liu H, et al. Loss of PDZK1 expression activates PI3K\/AKT signaling via PTEN phosphorylation in gastric cancer. Cancer Lett. 2019;453:107\u201321.","journal-title":"Cancer Lett"},{"issue":"1","key":"3695_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","volume":"124","author":"C Dobie","year":"2021","unstructured":"Dobie C, Skropeta D. Insights into the role of sialylation in cancer progression and metastasis. Br J Cancer. 2021;124(1):76\u201390.","journal-title":"Br J Cancer"},{"key":"3695_CR9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.014126","volume":"296","author":"CM Britain","year":"2021","unstructured":"Britain CM, Bhalerao N, Silva AD, Chakraborty A, Buchsbaum DJ, Crowley MR, et al. Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells. J Biol Chem. 2021;296: 100034.","journal-title":"J Biol Chem"},{"issue":"2","key":"3695_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/2326-6066.CIR-19-0514","volume":"8","author":"M Kvorjak","year":"2020","unstructured":"Kvorjak M, Ahmed Y, Miller ML, Sriram R, Coronnello C, Hashash JG, et al. Cross-talk between colon cells and macrophages increases ST6GALNAC1 and MUC1-sTn expression in ulcerative colitis and colitis-associated colon cancer. Cancer Immunol Res. 2020;8(2):167\u201378.","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"3695_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41419-018-1101-0","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Zhao J, Ruan Y, Sun L, Xu C, Jiang H. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-beta1-induced EMT and confers paclitaxel resistance in ovarian cancer. Cell Death Dis. 2018;9(11):1102.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3695_CR12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/ijc.31891","volume":"144","author":"HL Yeo","year":"2019","unstructured":"Yeo HL, Fan TC, Lin RJ, Yu JC, Liao GS, Chen ES, et al. Sialylation of vasorin by ST3Gal1 facilitates TGF-beta1-mediated tumor angiogenesis and progression. Int J Cancer. 2019;144(8):1996\u20132007.","journal-title":"Int J Cancer"},{"key":"3695_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115091","volume":"165","author":"R Al Saoud","year":"2023","unstructured":"Al Saoud R, Hamrouni A, Idris A, Mousa WK, Abu IT. Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: a comprehensive review. Biomed Pharmacother. 2023;165: 115091.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3695_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00018-019-03288-x","volume":"77","author":"H Laubli","year":"2020","unstructured":"Laubli H, Varki A. Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses. Cell Mol Life Sci. 2020;77(4):593\u2013605.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"3695_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"3695_CR16","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.3390\/cancers14246133","volume":"14","author":"L Miro","year":"2022","unstructured":"Miro L, Lopez J, Guerrero PE, Martinez-Bosch N, Manero-Ruperez N, Moreno M, et al. Sialyltransferase inhibitor Ac53FaxNeu5Ac reverts the malignant phenotype of pancreatic cancer cells, and reduces tumor volume and favors T-cell infiltrates in mice. Cancers. 2022;14(24):6133.","journal-title":"Cancers"},{"issue":"15","key":"3695_CR17","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1158\/0008-5472.CAN-22-3398","volume":"83","author":"X Shu","year":"2023","unstructured":"Shu X, Li J, Chan UI, Su SM, Shi C, Zhang X, et al. BRCA1 insufficiency induces a hypersialylated acidic tumor microenvironment that promotes metastasis and immunotherapy resistance. Cancer Res. 2023;83(15):2614\u201333.","journal-title":"Cancer Res"},{"issue":"6","key":"3695_CR18","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1021\/acsami.2c18601","volume":"15","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu CH, Mo J, Zheng XJ, Chen YF, Yang AQ, et al. Self-assembled core-shell nanoscale coordination polymer nanoparticles carrying a sialyltransferase inhibitor for cancer metastasis inhibition. ACS Appl Mater Interfaces. 2023;15(6):7713\u201324.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"3695_CR19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449\u201358.","journal-title":"Nat Med"},{"issue":"4","key":"3695_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10120-023-01379-0","volume":"26","author":"Y Chen","year":"2023","unstructured":"Chen Y, Cai G, Jiang J, He C, Chen Y, Ding Y, et al. Proteomic profiling of gastric cancer with peritoneal metastasis identifies a protein signature associated with immune microenvironment and patient outcome. Gastric Cancer. 2023;26(4):504\u201316.","journal-title":"Gastric Cancer"},{"issue":"7269","key":"3695_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108\u201312.","journal-title":"Nature"},{"issue":"1","key":"3695_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Li R, Zhou H, Chang X. New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation. Cell Mol Biol Lett. 2024;29(1):21.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3695_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s42003-023-05208-z","volume":"6","author":"JD Mannheimer","year":"2023","unstructured":"Mannheimer JD, Tawa G, Gerhold D, Braisted J, Sayers CM, McEachron TA, et al. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans. Commun Biol. 2023;6(1):856.","journal-title":"Commun Biol"},{"issue":"11","key":"3695_CR24","doi-asserted-by":"publisher","first-page":"nwac177","DOI":"10.1093\/nsr\/nwac177","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Xing F, Wang Y, Xiao J, An Z, Xu Y. Molecular bases of morphologically diffused tumors across multiple cancer types. Natl Sci Rev. 2022;9(11):nwac177.","journal-title":"Natl Sci Rev"},{"key":"3695_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3389\/fonc.2020.00401","volume":"10","author":"H Sun","year":"2020","unstructured":"Sun H, Zhou Y, Jiang H, Xu Y. Elucidation of functional roles of sialic acids in cancer migration. Front Oncol. 2020;10:401.","journal-title":"Front Oncol"},{"key":"3695_CR26","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1","key":"3695_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"5","key":"3695_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"3","key":"3695_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12(3):670\u201391.","journal-title":"Cancer Discov"},{"issue":"11","key":"3695_CR30","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"3","key":"3695_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with Census. Nat Methods. 2017;14(3):309\u201315.","journal-title":"Nat Methods"},{"issue":"24","key":"3695_CR32","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.21.02745","volume":"40","author":"YX Gwee","year":"2022","unstructured":"Gwee YX, Chia DKA, So J, Ceelen W, Yong WP, Tan P, et al. Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis. J Clin Oncol. 2022;40(24):2830.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3695_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/SLA.0000000000001542","volume":"263","author":"SR Markar","year":"2016","unstructured":"Markar SR, Mikhail S, Malietzis G, Athanasiou T, Mariette C, Sasako M, et al. Influence of surgical resection of hepatic metastases from gastric adenocarcinoma on long-term survival: systematic review and pooled analysis. Ann Surg. 2016;263(6):1092\u2013101.","journal-title":"Ann Surg"},{"issue":"11","key":"3695_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007805","volume":"11","author":"K Boelaars","year":"2023","unstructured":"Boelaars K, Goossens-Kruijssen L, Wang D, de Winde CM, Rodriguez E, Lindijer D, et al. Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer. J Immunother Cancer. 2023;11(11): e007805.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"3695_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112475","volume":"42","author":"H Egan","year":"2023","unstructured":"Egan H, Treacy O, Lynch K, Leonard NA, O\u2019Malley G, Reidy E, et al. Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment. Cell Rep. 2023;42(5): 112475.","journal-title":"Cell Rep"},{"issue":"3","key":"3695_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"3695_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101110","volume":"90","author":"A Gonzalez-Gil","year":"2023","unstructured":"Gonzalez-Gil A, Li TA, Kim J, Schnaar RL. Human sialoglycan ligands for immune inhibitory Siglecs. Mol Aspects Med. 2023;90: 101110.","journal-title":"Mol Aspects Med"},{"issue":"11","key":"3695_CR38","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/neuonc\/noad101","volume":"25","author":"U Kuliesiute","year":"2023","unstructured":"Kuliesiute U, Joseph K, Straehle J, Ravi VM, Kueckelhaus J, Kada Benotmane J, et al. Sialic acid metabolism orchestrates transcellular connectivity and signalling in glioblastoma. Neuro Oncol. 2023;25(11):1963\u201375.","journal-title":"Neuro Oncol"},{"issue":"705","key":"3695_CR39","doi-asserted-by":"publisher","first-page":"eadf302","DOI":"10.1126\/scitranslmed.adf5302","volume":"15","author":"P Schmassmann","year":"2023","unstructured":"Schmassmann P, Roux J, Buck A, Tatari N, Hogan S, Wang J, et al. Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. Sci Transl Med. 2023;15(705):eadf302.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3695_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.6152","volume":"261","author":"E Scott","year":"2023","unstructured":"Scott E, Archer Goode E, Garnham R, Hodgson K, Orozco-Moreno M, Turner H, et al. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. J Pathol. 2023;261(1):71\u201384.","journal-title":"J Pathol"},{"issue":"1","key":"3695_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2020;38(1):1\u201310.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3695_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107625","volume":"31","author":"H Brunton","year":"2020","unstructured":"Brunton H, Caligiuri G, Cunningham R, Upstill-Goddard R, Bailey UM, Garner IM, et al. HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer. Cell Rep. 2020;31(6): 107625.","journal-title":"Cell Rep"},{"issue":"32","key":"3695_CR43","doi-asserted-by":"publisher","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","volume":"112","author":"A Daemen","year":"2015","unstructured":"Daemen A, Peterson D, Sahu N, McCord R, Du X, Liu B, et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc Natl Acad Sci USA. 2015;112(32):E4410\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"3695_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/carcin\/bgae056","volume":"45","author":"P Moreno","year":"2024","unstructured":"Moreno P, Ohara Y, Craig AJ, Liu H, Yang S, Dorsey TH, et al. ADRA2A promotes the classical\/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. Carcinogenesis. 2024;45(11):845\u201356.","journal-title":"Carcinogenesis"},{"issue":"12","key":"3695_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113434","volume":"42","author":"Y Ohara","year":"2023","unstructured":"Ohara Y, Tang W, Liu H, Yang S, Dorsey TH, Cawley H, et al. SERPINB3-MYC axis induces the basal-like\/squamous subtype and enhances disease progression in pancreatic cancer. Cell Rep. 2023;42(12): 113434.","journal-title":"Cell Rep"},{"issue":"10","key":"3695_CR46","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/glycob\/cwab068","volume":"31","author":"S Grabenstein","year":"2021","unstructured":"Grabenstein S, Barnard KN, Anim M, Armoo A, Weichert WS, Bertozzi CR, et al. Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway. Glycobiology. 2021;31(10):1279\u201394.","journal-title":"Glycobiology"},{"issue":"9","key":"3695_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei Y, Wang X, Zhang J, Liu D, He J, Huang C, et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat Cancer. 2023;4(9):1273\u201391.","journal-title":"Nat Cancer"},{"issue":"12","key":"3695_CR48","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-22-1488","volume":"29","author":"H Thiesler","year":"2023","unstructured":"Thiesler H, Gretenkort L, Hoffmeister L, Albers I, Ohlmeier L, Rockle I, et al. Proinflammatory macrophage activation by the polysialic acid-Siglec-16 axis is linked to increased survival of patients with glioblastoma. Clin Cancer Res. 2023;29(12):2266\u201379.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3695_CR49","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1002\/jcb.27646","volume":"120","author":"M Najafi","year":"2019","unstructured":"Najafi M, Hashemi Goradel N, Farhood B, Salehi E, Nashtaei MS, Khanlarkhani N, et al. Macrophage polarity in cancer: a review. J Cell Biochem. 2019;120(3):2756\u201365.","journal-title":"J Cell Biochem"},{"issue":"3","key":"3695_CR50","first-page":"1449","volume":"21","author":"L Ou","year":"2020","unstructured":"Ou L, He X, Liu N, Song Y, Li J, Gao L, et al. Sialylation of FGFR1 by ST6Gal-I overexpression contributes to ovarian cancer cell migration and chemoresistance. Mol Med Rep. 2020;21(3):1449\u201360.","journal-title":"Mol Med Rep"},{"key":"3695_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fbioe.2019.00252","volume":"7","author":"A Natoni","year":"2019","unstructured":"Natoni A, Bohara R, Pandit A, O\u2019Dwyer M. Targeted approaches to inhibit sialylation of multiple myeloma in the bone marrow microenvironment. Front Bioeng Biotechnol. 2019;7:252.","journal-title":"Front Bioeng Biotechnol"},{"issue":"21","key":"3695_CR52","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1038\/s41388-021-01801-w","volume":"40","author":"HO Duarte","year":"2021","unstructured":"Duarte HO, Rodrigues JG, Gomes C, Hensbergen PJ, Ederveen ALH, de Ru AH, et al. ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab. Oncogene. 2021;40(21):3719\u201333.","journal-title":"Oncogene"},{"issue":"10389","key":"3695_CR53","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","volume":"401","author":"K Shitara","year":"2023","unstructured":"Shitara K, Lordick F, Bang YJ, Enzinger P, Ilson D, Shah MA, et al. Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. Lancet. 2023;401(10389):1655\u201368.","journal-title":"Lancet"},{"issue":"2","key":"3695_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/med.21407","volume":"37","author":"R Szabo","year":"2017","unstructured":"Szabo R, Skropeta D. Advancement of sialyltransferase inhibitors: therapeutic challenges and opportunities. Med Res Rev. 2017;37(2):219\u201370.","journal-title":"Med Res Rev"},{"issue":"10","key":"3695_CR55","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1245\/s10434-011-1636-0","volume":"18","author":"M Hiraki","year":"2011","unstructured":"Hiraki M, Kitajima Y, Koga Y, Tanaka T, Nakamura J, Hashiguchi K, et al. Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients. Ann Surg Oncol. 2011;18(10):3013\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3695_CR56","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s10120-020-01065-5","volume":"23","author":"S Kaji","year":"2020","unstructured":"Kaji S, Irino T, Kusuhara M, Makuuchi R, Yamakawa Y, Tokunaga M, et al. Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer. 2020;23(5):874\u201383.","journal-title":"Gastric Cancer"},{"issue":"7","key":"3695_CR57","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1245\/s10434-018-6480-z","volume":"25","author":"K Sawaki","year":"2018","unstructured":"Sawaki K, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, et al. Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer. Ann Surg Oncol. 2018;25(7):2083\u201390.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3695_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130472","volume":"10","author":"M Tokuhisa","year":"2015","unstructured":"Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K, et al. Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS ONE. 2015;10(7): e0130472.","journal-title":"PLoS ONE"},{"issue":"4","key":"3695_CR59","first-page":"2281","volume":"41","author":"Y Wu","year":"2019","unstructured":"Wu Y, Xu M, He R, Xu K, Ma Y. ARHGAP6 regulates the proliferation, migration and invasion of lung cancer cells. Oncol Rep. 2019;41(4):2281\u2013888.","journal-title":"Oncol Rep"},{"issue":"2","key":"3695_CR60","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s13577-023-00860-3","volume":"36","author":"W Chen","year":"2023","unstructured":"Chen W, Tan M, Yu C, Liao G, Kong D, Bai J, et al. ARHGAP6 inhibits bladder cancer cell viability, migration, and invasion via beta-catenin signaling and enhances mitomycin C sensitivity. Hum Cell. 2023;36(2):786\u201397.","journal-title":"Hum Cell"},{"issue":"2","key":"3695_CR61","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s13277-015-4502-z","volume":"37","author":"J Li","year":"2016","unstructured":"Li J, Liu Y, Yin Y. Inhibitory effects of Arhgap6 on cervical carcinoma cells. Tumour Biol. 2016;37(2):1411\u201325.","journal-title":"Tumour Biol"},{"key":"3695_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173994","volume":"898","author":"Q Yin","year":"2021","unstructured":"Yin Q, Gu J, Qi Y, Lu Y, Yang L, Liu J, et al. ADAM28 from both endothelium and gastric cancer cleaves von Willebrand Factor to eliminate von Willebrand factor-induced apoptosis of gastric cancer cells. Eur J Pharmacol. 2021;898: 173994.","journal-title":"Eur J Pharmacol"},{"key":"3695_CR63","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3389\/fonc.2020.01532","volume":"10","author":"Z Chen","year":"2020","unstructured":"Chen Z, Yan X, Du GW, Tuoheti K, Bai XJ, Wu HH, et al. Complement C7 (C7), a potential tumor suppressor, is an immune-related prognostic biomarker in prostate cancer (PC). Front Oncol. 2020;10:1532.","journal-title":"Front Oncol"},{"key":"3695_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724250","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhao Y, Liu X, Fu L, Gu F, Ma Y. High expression of complement component C7 indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy. Front Oncol. 2021;11: 724250.","journal-title":"Front Oncol"},{"key":"3695_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.968165","volume":"13","author":"M Khan","year":"2022","unstructured":"Khan M, Lin J, Wang B, Chen C, Huang Z, Tian Y, et al. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma. Front Immunol. 2022;13: 968165.","journal-title":"Front Immunol"},{"issue":"3","key":"3695_CR66","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.devcel.2018.04.009","volume":"45","author":"J Chen","year":"2018","unstructured":"Chen J, Castelvecchi GD, Li-Villarreal N, Raught B, Krezel AM, McNeill H, et al. Atypical cadherin Dachsous1b interacts with Ttc28 and Aurora B to control microtubule dynamics in embryonic cleavages. Dev Cell. 2018;45(3):376\u201391.e5.","journal-title":"Dev Cell"},{"issue":"2","key":"3695_CR67","doi-asserted-by":"publisher","first-page":"djv326","DOI":"10.1093\/jnci\/djv326","volume":"108","author":"YK Chong","year":"2016","unstructured":"Chong YK, Sandanaraj E, Koh LW, Thangaveloo M, Tan MS, Koh GR, et al. ST3GAL1-associated transcriptomic program in glioblastoma tumor growth, invasion, and prognosis. J Natl Cancer Inst. 2016;108(2):djv326.","journal-title":"J Natl Cancer Inst"},{"key":"3695_CR68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2018.07.026","volume":"434","author":"TC Fan","year":"2018","unstructured":"Fan TC, Yeo HL, Hsu HM, Yu JC, Ho MY, Lin WD, et al. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells. Cancer Lett. 2018;434:184\u201395.","journal-title":"Cancer Lett"},{"issue":"1","key":"3695_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/2326-6066.CIR-20-0203","volume":"9","author":"WD Lin","year":"2021","unstructured":"Lin WD, Fan TC, Hung JT, Yeo HL, Wang SH, Kuo CW, et al. Sialylation of CD55 by ST3GAL1 facilitates immune evasion in cancer. Cancer Immunol Res. 2021;9(1):113\u201322.","journal-title":"Cancer Immunol Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03695-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T15:03:37Z","timestamp":1740236617000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3695"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03695-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Human ethical approval was obtained from the Clinical Research Ethics Committee of the First Affiliated Hospital of Zhejiang University School of Medicine (No. 20220366B). The animal ethical approval was confirmed by the ethics board of the Laboratory Animal Center of Zhejiang University School of Medicine (No. 24905). Informed consent was obtained from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}